Sulla via del Dolore - The path of Pain

The studies conducted on the employment of the analgesic drug have considered that drugs that had the ability to decrease the firing of impulses that from the periphery they are propagated to the brain. After the cloning of TRPV1,1,2 occurred in the last ten years of research, the focus has shift...

Full description

Bibliographic Details
Main Authors: Francesco Amato, Erminia Gilda Morrone
Format: Article
Language:English
Published: Publiediting 2017-01-01
Series:Pathos
Subjects:
Online Access:https://www.pathos-journal.com/2016_3_173.html
id doaj-6b392e783f804f9898229ead01217174
record_format Article
spelling doaj-6b392e783f804f9898229ead012171742020-11-24T22:54:59ZengPublieditingPathos1593-23542385-07442017-01-01233Sulla via del Dolore - The path of PainFrancesco Amato0 Erminia Gilda Morrone1Direttore UOC Ter Dolore e CP AO Cosenza Centro Hub Regionale Biologa, Associazione Centro Studi Terapia del Dolore CosenzaThe studies conducted on the employment of the analgesic drug have considered that drugs that had the ability to decrease the firing of impulses that from the periphery they are propagated to the brain. After the cloning of TRPV1,1,2 occurred in the last ten years of research, the focus has shifted to the Transient Receptor Potential (TRPV1) which sees them involved in many inflammatory and neuropathic processes. For these reasons TRPV1 has become a viable drug target for clinical use in the management of pain. This short review will provide a general picture of the physiological and pathophysiological roles of the TRPV1 channel and of their structural, pharmacological and biophysical properties, as therapeutic agents for the management of chronic and neuropathic pain.https://www.pathos-journal.com/2016_3_173.htmlIon channelsTRPV1painanalgesianeuropathic infiammation
collection DOAJ
language English
format Article
sources DOAJ
author Francesco Amato
Erminia Gilda Morrone
spellingShingle Francesco Amato
Erminia Gilda Morrone
Sulla via del Dolore - The path of Pain
Pathos
Ion channels
TRPV1
pain
analgesia
neuropathic infiammation
author_facet Francesco Amato
Erminia Gilda Morrone
author_sort Francesco Amato
title Sulla via del Dolore - The path of Pain
title_short Sulla via del Dolore - The path of Pain
title_full Sulla via del Dolore - The path of Pain
title_fullStr Sulla via del Dolore - The path of Pain
title_full_unstemmed Sulla via del Dolore - The path of Pain
title_sort sulla via del dolore - the path of pain
publisher Publiediting
series Pathos
issn 1593-2354
2385-0744
publishDate 2017-01-01
description The studies conducted on the employment of the analgesic drug have considered that drugs that had the ability to decrease the firing of impulses that from the periphery they are propagated to the brain. After the cloning of TRPV1,1,2 occurred in the last ten years of research, the focus has shifted to the Transient Receptor Potential (TRPV1) which sees them involved in many inflammatory and neuropathic processes. For these reasons TRPV1 has become a viable drug target for clinical use in the management of pain. This short review will provide a general picture of the physiological and pathophysiological roles of the TRPV1 channel and of their structural, pharmacological and biophysical properties, as therapeutic agents for the management of chronic and neuropathic pain.
topic Ion channels
TRPV1
pain
analgesia
neuropathic infiammation
url https://www.pathos-journal.com/2016_3_173.html
work_keys_str_mv AT francescoamato sullaviadeldolorethepathofpain
AT erminiagildamorrone sullaviadeldolorethepathofpain
_version_ 1725658444480905216